H. Decederfelt

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Mario Roederer, Sumana Chakravarty, Martha C Nason, 2016, Nature Medicine.

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

J. Mascola, T. Pierson, C. Andrews, 2017, The Lancet.

Correction: Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Andrea A. Berry, S. Hoffman, S. Kappe, 2016, Nature Medicine.

Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

S. Hoffman, S. Bhatia, J. Duan, 2021, Nature.

Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice

P. Scaria, Y. Wu, B. Swihart, 2020, medRxiv.

Handling of gene-transfer products by the National Institutes of Health Clinical Center pharmacy department.

G. Grimes, H. Decederfelt, C. Daniels, 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice

P. Scaria, B. Swihart, Yimin Wu, 2021, The Journal of clinical investigation.